SEC INSIDER TRANSACTIONS

INTUITIVE SURGICAL INC (ISRG) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

ISRG · INTUITIVE SURGICAL INC

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-10-27 · 24 filings · fetched 2026-10-27T16:20:31Z

Recent reported activity

0purchase rows on this page

12sale rows on this page

78matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-10-23Filed 2026-10-26	Widman FredrikOfficer · VP Corporate Controller Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 15, 2027. F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $444.44 to $458.02 as follows: 40 shares sold at $444.44; 120 shares sold at $445.55 to $446.44; 80 shares sold at $446.76; 120 shares sold at $448.14 to $448.37; 200 shares sold at $449.30 to $450.22; 80 shares sold at $450.34 to $451.17; 1,447 shares sold at $451.98 to $452.97; 480 shares sold at $453.01 to $453.84; 360 shares sold at $454.02 to $455.00; 400 shares sold at $455.27 to $455.78; 480 shares sold at $456.33 to $457.19; and 240 shares sold at $457.42 to $458.02. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F3 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. F4 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. F5 Non-statutory stock option granted pursuant to the 2010 Incentive Awards Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. F6 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. F7 7/48th of the shares subject to the option vest on the one-month anniversary measured from August 10, 2023, and 1/48th of the total number of shares vest in forty-one (41) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. References: F1	M Exercise / conversionCommon Stock · Non-derivative	312A	290.33	Direct	Form 4 ↗0001897970-26-000010
2026-10-23Filed 2026-10-26	Widman FredrikOfficer · VP Corporate Controller Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 15, 2027. F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $444.44 to $458.02 as follows: 40 shares sold at $444.44; 120 shares sold at $445.55 to $446.44; 80 shares sold at $446.76; 120 shares sold at $448.14 to $448.37; 200 shares sold at $449.30 to $450.22; 80 shares sold at $450.34 to $451.17; 1,447 shares sold at $451.98 to $452.97; 480 shares sold at $453.01 to $453.84; 360 shares sold at $454.02 to $455.00; 400 shares sold at $455.27 to $455.78; 480 shares sold at $456.33 to $457.19; and 240 shares sold at $457.42 to $458.02. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F3 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. F4 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. F5 Non-statutory stock option granted pursuant to the 2010 Incentive Awards Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. F6 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. F7 7/48th of the shares subject to the option vest on the one-month anniversary measured from August 10, 2023, and 1/48th of the total number of shares vest in forty-one (41) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. References: F1	M Exercise / conversionCommon Stock · Non-derivative	307A	229.39	Direct	Form 4 ↗0001897970-26-000010
2026-10-23Filed 2026-10-26	Widman FredrikOfficer · VP Corporate Controller Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 15, 2027. F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $444.44 to $458.02 as follows: 40 shares sold at $444.44; 120 shares sold at $445.55 to $446.44; 80 shares sold at $446.76; 120 shares sold at $448.14 to $448.37; 200 shares sold at $449.30 to $450.22; 80 shares sold at $450.34 to $451.17; 1,447 shares sold at $451.98 to $452.97; 480 shares sold at $453.01 to $453.84; 360 shares sold at $454.02 to $455.00; 400 shares sold at $455.27 to $455.78; 480 shares sold at $456.33 to $457.19; and 240 shares sold at $457.42 to $458.02. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F3 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. F4 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. F5 Non-statutory stock option granted pursuant to the 2010 Incentive Awards Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. F6 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. F7 7/48th of the shares subject to the option vest on the one-month anniversary measured from August 10, 2023, and 1/48th of the total number of shares vest in forty-one (41) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. References: F1	M Exercise / conversionCommon Stock · Non-derivative	307A	304.67	Direct	Form 4 ↗0001897970-26-000010
2026-10-10Filed 2026-10-13	WADORS PATRICIA LOfficer · SVP Chief Human Resources Offi Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the tax withholding obligations. The net shares were deposited into the holders account. F2 Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period. References: F2	M Exercise / conversionRestricted Stock Units - 10-10-2024 · Derivative	2,140D	0	Direct	Form 4 ↗0001274559-26-000005
2026-10-10Filed 2026-10-13	WADORS PATRICIA LOfficer · SVP Chief Human Resources Offi Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the tax withholding obligations. The net shares were deposited into the holders account. F2 Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period. References: F1	F WithholdingCommon Stock · Non-derivative	1,062D	423.96	Direct	Form 4 ↗0001274559-26-000005
2026-10-10Filed 2026-10-13	WADORS PATRICIA LOfficer · SVP Chief Human Resources Offi Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the tax withholding obligations. The net shares were deposited into the holders account. F2 Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period. References: F1	M Exercise / conversionCommon Stock · Non-derivative	2,140A	0	Direct	Form 4 ↗0001274559-26-000005
2026-10-10Filed 2026-10-13	LOEB GARYOfficer · EVP & Chief Legal and Complian Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the tax withholding obligations. The net shares were deposited into the holders account. F2 Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period. References: F2	M Exercise / conversionRestricted Stock Units · Derivative	2,612D	0	Direct	Form 4 ↗0001561733-26-000016
2026-10-10Filed 2026-10-13	LOEB GARYOfficer · EVP & Chief Legal and Complian Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the tax withholding obligations. The net shares were deposited into the holders account. F2 Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period. References: F1	F WithholdingCommon Stock · Non-derivative	1,296D	423.96	Direct	Form 4 ↗0001561733-26-000016
2026-10-10Filed 2026-10-13	LOEB GARYOfficer · EVP & Chief Legal and Complian Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the tax withholding obligations. The net shares were deposited into the holders account. F2 Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period. References: F1	M Exercise / conversionCommon Stock · Non-derivative	2,612A	0	Direct	Form 4 ↗0001561733-26-000016
2026-09-15Filed 2026-09-16	Widman FredrikOfficer · VP Corporate Controller Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 15, 2027. F2 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. F3 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. References: F1, F3	M Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative	543D	0	Direct	Form 4 ↗0001897970-26-000008
2026-09-15Filed 2026-09-16	Widman FredrikOfficer · VP Corporate Controller Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 15, 2027. F2 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. F3 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. References: F1, F2	M Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative	546D	0	Direct	Form 4 ↗0001897970-26-000008
2026-09-15Filed 2026-09-16	Widman FredrikOfficer · VP Corporate Controller Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 15, 2027. F2 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. F3 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. References: F1	S Sale (market/private)Common Stock · Non-derivative	543D	374.44	Direct	Form 4 ↗0001897970-26-000008
2026-09-15Filed 2026-09-16	Widman FredrikOfficer · VP Corporate Controller Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 15, 2027. F2 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. F3 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. References: F1	M Exercise / conversionCommon Stock · Non-derivative	543A	109.4856	Direct	Form 4 ↗0001897970-26-000008
2026-09-15Filed 2026-09-16	Widman FredrikOfficer · VP Corporate Controller Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 15, 2027. F2 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. F3 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. References: F1	S Sale (market/private)Common Stock · Non-derivative	546D	374.44	Direct	Form 4 ↗0001897970-26-000008
2026-09-15Filed 2026-09-16	Widman FredrikOfficer · VP Corporate Controller Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 15, 2027. F2 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. F3 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. References: F1	M Exercise / conversionCommon Stock · Non-derivative	546A	79.6378	Direct	Form 4 ↗0001897970-26-000008
2026-09-11Filed 2026-09-11	Brosius MarkOfficer · EVP & Chief Mfg and Supply Cha Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027. References: F1	S Sale (market/private)Common Stock · Non-derivative	25D	365.79	Direct	Form 4 ↗0002010300-26-000033
2026-09-10Filed 2026-09-11	Brosius MarkOfficer · EVP & Chief Mfg and Supply Cha Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027. References: F1	S Sale (market/private)Common Stock · Non-derivative	23D	347.66	Direct	Form 4 ↗0002010300-26-000033
2026-09-09Filed 2026-09-09	Brosius MarkOfficer · EVP & Chief Mfg and Supply Cha Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027. References: F1	S Sale (market/private)Common Stock · Non-derivative	23D	350.2	Direct	Form 4 ↗0002010300-26-000031
2026-09-08Filed 2026-09-09	Brosius MarkOfficer · EVP & Chief Mfg and Supply Cha Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027. References: F1	S Sale (market/private)Common Stock · Non-derivative	46D	361.23	Direct	Form 4 ↗0002010300-26-000031
2026-08-21Filed 2026-08-21	Brosius MarkOfficer · EVP & Chief Mfg and Supply Cha Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027. References: F1	S Sale (market/private)Common Stock · Non-derivative	77D	375.57	Direct	Form 4 ↗0002010300-26-000029
2026-08-20Filed 2026-08-21	Brosius MarkOfficer · EVP & Chief Mfg and Supply Cha Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027. References: F1	S Sale (market/private)Common Stock · Non-derivative	77D	396.37	Direct	Form 4 ↗0002010300-26-000029
2026-08-19Filed 2026-08-19	Brosius MarkOfficer · EVP & Chief Mfg and Supply Cha Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027. References: F1	S Sale (market/private)Common Stock · Non-derivative	77D	394.26	Direct	Form 4 ↗0002010300-26-000027
2026-08-18Filed 2026-08-19	Brosius MarkOfficer · EVP & Chief Mfg and Supply Cha Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027. References: F1	S Sale (market/private)Common Stock · Non-derivative	77D	394	Direct	Form 4 ↗0002010300-26-000027
2026-08-17Filed 2026-08-19	Brosius MarkOfficer · EVP & Chief Mfg and Supply Cha Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027. References: F1	S Sale (market/private)Common Stock · Non-derivative	77D	390.67	Direct	Form 4 ↗0002010300-26-000027
2026-08-11Filed 2026-08-11	Ladd Amy LDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 15, 2027. References: F1	S Sale (market/private)Common Stock · Non-derivative	72D	393.1	Direct	Form 4 ↗0001781750-26-000006

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.